Clinical Trials Browser

Advanced Breast Cancer × sacituzumab govitecan × 1 year × Clear all

NCT07359404 2026-01-22

Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC

Phase 2 Enrolling by invitation

Advanced Breast Cancer

NCT06612203 2025-12-05

WIN-B

Phase 1/2 Active not recruiting

Advanced Breast Cancer